5VAV

Design of a novel cyclic peptide that alleviates symptoms in a murine model of inflammatory bowel disease

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H TOCSY	0.2 mM cyc-MC12, 10 % D2O, 90 % H2O	90% H2O/10% D2O	1	5	1 atm	290	Bruker AVANCE III 600
2	2D 1H-1H COSY	0.2 mM cyc-MC12, 10 % D2O, 90 % H2O	90% H2O/10% D2O	1	5	1 atm	290	Bruker AVANCE III 600
3	2D 1H-1H NOESY	0.2 mM cyc-MC12, 10 % D2O, 90 % H2O	90% H2O/10% D2O	1	5	1 atm	290	Bruker AVANCE III 600
4	2D 1H-15N HSQC	0.2 mM cyc-MC12, 10 % D2O, 90 % H2O	90% H2O/10% D2O	1	5	1 atm	290	Bruker AVANCE III 600
5	2D 1H-13C HSQC	0.2 mM cyc-MC12, 10 % D2O, 90 % H2O	90% H2O/10% D2O	1	5	1 atm	290	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNMR		CCPN
2	data analysis	CcpNMR		CCPN
3	refinement	CYANA		Guntert, Mumenthaler and Wuthrich
5	collection	TopSpin		Bruker Biospin
7	data analysis	TALOS		Cornilescu, Delaglio and Bax
8	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich